Kshiti Dholakia to Humans
This is a "connection" page, showing publications Kshiti Dholakia has written about Humans.
Connection Strength
0.034
-
Interaction between tumor cell TNFR2 and monocyte membrane-bound TNF-a triggers tumorigenic inflammation in neuroblastoma. J Immunother Cancer. 2023 03; 11(3).
Score: 0.005
-
Comparative Analysis and Isoform-Specific Therapeutic Vulnerabilities of KRAS Mutations in Non-Small Cell Lung Cancer. Clin Cancer Res. 2022 04 14; 28(8):1640-1650.
Score: 0.005
-
K-Ras and p53 mouse model with molecular characteristics of human rhabdomyosarcoma and translational applications. Dis Model Mech. 2022 02 01; 15(2).
Score: 0.005
-
Combination of Type I and Type II MET Tyrosine Kinase Inhibitors as Therapeutic Approach to Prevent Resistance. Mol Cancer Ther. 2022 02; 21(2):322-335.
Score: 0.005
-
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer. Sci Transl Med. 2021 Sep; 13(609):eabb3738.
Score: 0.005
-
MTA1-Dependent Anticancer Activity of Gnetin C in Prostate Cancer. Nutrients. 2019 Sep 04; 11(9).
Score: 0.004
-
In Vitro Anticancer Properties of Table Grape Powder Extract (GPE) in Prostate Cancer. Nutrients. 2018 Nov 20; 10(11).
Score: 0.004